 | | J2G | | Name: | 4-methoxy-3-{[2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl]sulfamoyl}benzoic acid | | Formula: | C20 H21 F3 N2 O5 S | | SMILES: | COc1ccc(cc1S(Nc2c(cc(cc2)C(F)(F)F)N3CCCCC3)(=O)=O)C(O)=O | | InChi: | InChI=1S/C20H21F3N2O5S/c1-30-17-8-5-13(19(26)27)11-18(17)31(28,29)24-15-7-6-14(20(21,22)23)12-16(15)25-9-3-2-4-10-25/h5-8,11-12,24H,2-4,9-10H2,1H3,(H,26,27) | | Definition date: | 2018-08-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | 4-methoxy-3-{[2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl]sulfamoyl}benzoic acid |
|
 | | J4Y | | Name: | (1S,2S)-N'-(chloroacetyl)-2-phenylcyclopropane-1-carbohydrazide | | Formula: | C12 H13 Cl N2 O2 | | SMILES: | N(NC(=O)C1C(C1)c2ccccc2)C(CCl)=O | | InChi: | InChI=1S/C12H13ClN2O2/c13-7-11(16)14-15-12(17)10-6-9(10)8-4-2-1-3-5-8/h1-5,9-10H,6-7H2,(H,14,16)(H,15,17)/t9-,10+/m1/s1 | | Definition date: | 2018-08-13 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | (1S,2S)-N'-(chloroacetyl)-2-phenylcyclopropane-1-carbohydrazide |
|
 | | H2H | | Name: | (2~{R})-4-[6-(2-fluoranyl-4-methoxy-phenyl)-3-oxidanylidene-1~{H}-pyrrolo[1,2-c]imidazol-2-yl]-2-methyl-2-methylsulfonyl-~{N}-oxidanyl-butanamide | | Formula: | C19 H22 F N3 O6 S | | SMILES: | COc1ccc(c(F)c1)c2cn3C(=O)N(CC[C](C)(C(=O)NO)[S](C)(=O)=O)Cc3c2 | | InChi: | InChI=1S/C19H22FN3O6S/c1-19(17(24)21-26,30(3,27)28)6-7-22-11-13-8-12(10-23(13)18(22)25)15-5-4-14(29-2)9-16(15)20/h4-5,8-10,26H,6-7,11H2,1-3H3,(H,21,24)/t19-/m1/s1 | | Definition date: | 2018-11-09 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | (2~{R})-4-[6-(2-fluoranyl-4-methoxy-phenyl)-3-oxidanylidene-1~{H}-pyrrolo[1,2-c]imidazol-2-yl]-2-methyl-2-methylsulfonyl-~{N}-oxidanyl-butanamide |
|
 | | BQX | | Name: | 1-[4-(6-aminopurin-9-yl)butylsulfamoyl]-3-[4-[(4~{S})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]butyl]urea | | Formula: | C19 H30 N10 O4 S2 | | SMILES: | Nc1ncnc2n(CCCCN[S](=O)(=O)NC(=O)NCCCC[CH]3SC[CH]4NC(=O)N[CH]34)cnc12 | | InChi: | InChI=1S/C19H30N10O4S2/c20-16-15-17(23-10-22-16)29(11-24-15)8-4-3-7-25-35(32,33)28-18(30)21-6-2-1-5-13-14-12(9-34-13)26-19(31)27-14/h10-14,25H,1-9H2,(H2,20,22,23)(H2,21,28,30)(H2,26,27,31)/t12-,13-,14-/m0/s1 | | Definition date: | 2018-12-17 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | 1-[4-(6-aminopurin-9-yl)butylsulfamoyl]-3-[4-[(4~{S})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]butyl]urea |
|
 | | KWE | | Name: | 3-(4-phenylbutylamino)-1,4-bis(phenylmethyl)pyrrole-2,5-dione | | Formula: | C28 H28 N2 O2 | | SMILES: | O=C1N(Cc2ccccc2)C(=O)C(=C1Cc3ccccc3)NCCCCc4ccccc4 | | InChi: | InChI=1S/C28H28N2O2/c31-27-25(20-23-15-6-2-7-16-23)26(28(32)30(27)21-24-17-8-3-9-18-24)29-19-11-10-14-22-12-4-1-5-13-22/h1-9,12-13,15-18,29H,10-11,14,19-21H2 | | Definition date: | 2019-07-02 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | 3-(4-phenylbutylamino)-1,4-bis(phenylmethyl)pyrrole-2,5-dione |
|
 | | KZB | | Name: | (2~{S},3~{R},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-[(1~{S},2~{R},3~{R},4~{R},5'~{S},6~{S},7~{R},8~{S},9~{R},12~{R},13~{R},15~{S},16~{S},18~{R})-5',7,9,13-tetramethyl-3,15-bis(oxidanyl)spiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane-6,2'-oxane]-16-yl]oxy-oxane-3,4,5-triol | | Formula: | C33 H54 O10 | | SMILES: | C[CH]1CC[C]2(OC1)O[CH]3[CH](O)[CH]4[CH]5CC[CH]6C[CH](O[CH]7O[CH](CO)[CH](O)[CH](O)[CH]7O)[CH](O)C[C]6(C)[CH]5CC[C]4(C)[CH]3[CH]2C | | InChi: | InChI=1S/C33H54O10/c1-15-7-10-33(40-14-15)16(2)23-29(43-33)26(37)24-18-6-5-17-11-21(41-30-28(39)27(38)25(36)22(13-34)42-30)20(35)12-32(17,4)19(18)8-9-31(23,24)3/h15-30,34-39H,5-14H2,1-4H3/t15-,16+,17+,18-,19+,20-,21-,22-,23+,24-,25-,26+,27+,28-,29+,30-,31-,32+,33-/m0/s1 | | Definition date: | 2019-07-06 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | (2~{S},3~{R},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-[(1~{S},2~{R},3~{R},4~{R},5'~{S},6~{S},7~{R},8~{S},9~{R},12~{R},13~{R},15~{S},16~{S},18~{R})-5',7,9,13-tetramethyl-3,15-bis(oxidanyl)spiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane-6,2'-oxane]-16-yl]oxy-oxane-3,4,5-triol |
|
 | | KZE | | Name: | [(3~{R},6~{Z},10~{Z},14~{Z},18~{Z})-3,7,11,15,19,23-hexamethyltetracosa-6,10,14,18,22-pentaenyl] dihydrogen phosphate | | Formula: | C30 H53 O4 P | | SMILES: | C[CH](CCO[P](O)(O)=O)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C | | InChi: | InChI=1S/C30H53O4P/c1-25(2)13-8-14-26(3)15-9-16-27(4)17-10-18-28(5)19-11-20-29(6)21-12-22-30(7)23-24-34-35(31,32)33/h13,15,17,19,21,30H,8-12,14,16,18,20,22-24H2,1-7H3,(H2,31,32,33)/b26-15-,27-17-,28-19-,29-21-/t30-/m1/s1 | | Definition date: | 2019-07-06 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | [(3~{R},6~{Z},10~{Z},14~{Z},18~{Z})-3,7,11,15,19,23-hexamethyltetracosa-6,10,14,18,22-pentaenyl] dihydrogen phosphate |
|
 | | L2Q | | Name: | [(1~{R})-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2~{S})-1-[[(1~{R},4~{a}~{R},8~{a}~{R})-4-oxidanylidene-2,3,4~{a},5,6,7,8,8~{a}-octahydro-1~{H}-naphthalen-1-yl]carbonyl]piperidine-2-carboxylate | | Formula: | C40 H54 N2 O8 | | SMILES: | COc1ccc(CC[CH](OC(=O)[CH]2CCCCN2C(=O)[CH]3CCC(=O)[CH]4CCCC[CH]34)c5cccc(OCCN6CCOCC6)c5)cc1OC | | InChi: | InChI=1S/C40H54N2O8/c1-46-37-18-14-28(26-38(37)47-2)13-17-36(29-8-7-9-30(27-29)49-25-22-41-20-23-48-24-21-41)50-40(45)34-12-5-6-19-42(34)39(44)33-15-16-35(43)32-11-4-3-10-31(32)33/h7-9,14,18,26-27,31-34,36H,3-6,10-13,15-17,19-25H2,1-2H3/t31-,32-,33-,34+,36-/m1/s1 | | Definition date: | 2019-07-16 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | [(1~{R})-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2~{S})-1-[[(1~{R},4~{a}~{R},8~{a}~{R})-4-oxidanylidene-2,3,4~{a},5,6,7,8,8~{a}-octahydro-1~{H}-naphthalen-1-yl]carbonyl]piperidine-2-carboxylate |
|
 | | DZR | | Name: | ~{N}-[[1-[2-(~{tert}-butylamino)-2-oxidanylidene-ethyl]piperidin-4-yl]methyl]-3-chloranyl-5-fluoranyl-benzamide | | Formula: | C19 H27 Cl F N3 O2 | | SMILES: | CC(C)(C)NC(=O)CN1CCC(CC1)CNC(=O)c2cc(F)cc(Cl)c2 | | InChi: | InChI=1S/C19H27ClFN3O2/c1-19(2,3)23-17(25)12-24-6-4-13(5-7-24)11-22-18(26)14-8-15(20)10-16(21)9-14/h8-10,13H,4-7,11-12H2,1-3H3,(H,22,26)(H,23,25) | | Definition date: | 2019-09-26 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | ~{N}-[[1-[2-(~{tert}-butylamino)-2-oxidanylidene-ethyl]piperidin-4-yl]methyl]-3-chloranyl-5-fluoranyl-benzamide |
|
 | | EA3 | | Name: | 4-chloranyl-2-cyclohexylsulfanyl-~{N}-(2-hydroxyethyl)-5-sulfamoyl-benzamide | | Formula: | C15 H21 Cl N2 O4 S2 | | SMILES: | N[S](=O)(=O)c1cc(C(=O)NCCO)c(SC2CCCCC2)cc1Cl | | InChi: | InChI=1S/C15H21ClN2O4S2/c16-12-9-13(23-10-4-2-1-3-5-10)11(15(20)18-6-7-19)8-14(12)24(17,21)22/h8-10,19H,1-7H2,(H,18,20)(H2,17,21,22) | | Definition date: | 2019-03-27 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | 4-chloranyl-2-cyclohexylsulfanyl-~{N}-(2-hydroxyethyl)-5-sulfamoyl-benzamide |
|
 | | KJG | | Name: | 2~3~,2~6~-dihydroxy[1~1~,2~1~:2~4~,3~1~-terphenyl]-2~2~,2~5~-dione | | Formula: | C18 H12 O4 | | SMILES: | O=C1C(=C(O)C(=O)C(=C1O)c2ccccc2)c3ccccc3 | | InChi: | InChI=1S/C18H12O4/c19-15-13(11-7-3-1-4-8-11)16(20)18(22)14(17(15)21)12-9-5-2-6-10-12/h1-10,19,22H | | Definition date: | 2018-12-14 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | 2~3~,2~6~-dihydroxy[1~1~,2~1~:2~4~,3~1~-terphenyl]-2~2~,2~5~-dione |
|
 | | N5D | | Name: | N-cyclopropyl-2-(4-{[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}-1H-pyrazol-1-yl)acetamide | | Formula: | C13 H16 N6 O3 | | SMILES: | N(c1cn(nc1)CC(NC2CC2)=O)C(Nc3cc(C)on3)=O | | InChi: | InChI=1S/C13H16N6O3/c1-8-4-11(18-22-8)17-13(21)16-10-5-14-19(6-10)7-12(20)15-9-2-3-9/h4-6,9H,2-3,7H2,1H3,(H,15,20)(H2,16,17,18,21) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-cyclopropyl-2-(4-{[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}-1H-pyrazol-1-yl)acetamide |
|
 | | N5S | | Name: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-4,4,4-trifluoro-3-hydroxy-3-(5-methylfuran-2-yl)butyl]urea | | Formula: | C14 H16 F3 N3 O4 | | SMILES: | N(C(NCCC(c1oc(C)cc1)(O)C(F)(F)F)=O)c2cc(C)on2 | | InChi: | InChI=1S/C14H16F3N3O4/c1-8-3-4-10(23-8)13(22,14(15,16)17)5-6-18-12(21)19-11-7-9(2)24-20-11/h3-4,7,22H,5-6H2,1-2H3,(H2,18,19,20,21)/t13-/m0/s1 | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[(3S)-4,4,4-trifluoro-3-hydroxy-3-(5-methylfuran-2-yl)butyl]urea |
|
 | | N5V | | Name: | N-ethyl-N'-1,3-thiazol-2-ylurea | | Formula: | C6 H9 N3 O S | | SMILES: | N(C(NCC)=O)c1nccs1 | | InChi: | InChI=1S/C6H9N3OS/c1-2-7-5(10)9-6-8-3-4-11-6/h3-4H,2H2,1H3,(H2,7,8,9,10) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-ethyl-N'-1,3-thiazol-2-ylurea |
|
 | | N64 | | Name: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[3-(4-phenylpiperazin-1-yl)propyl]urea | | Formula: | C18 H25 N5 O2 | | SMILES: | N(CCCN2CCN(c1ccccc1)CC2)C(Nc3cc(C)on3)=O | | InChi: | InChI=1S/C18H25N5O2/c1-15-14-17(21-25-15)20-18(24)19-8-5-9-22-10-12-23(13-11-22)16-6-3-2-4-7-16/h2-4,6-7,14H,5,8-13H2,1H3,(H2,19,20,21,24) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[3-(4-phenylpiperazin-1-yl)propyl]urea |
|
 | | N67 | | Name: | N-methyl-5-({[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}methyl)thiophene-2-sulfonamide | | Formula: | C11 H14 N4 O4 S2 | | SMILES: | N(Cc1sc(S(NC)(=O)=O)cc1)C(Nc2noc(c2)C)=O | | InChi: | InChI=1S/C11H14N4O4S2/c1-7-5-9(15-19-7)14-11(16)13-6-8-3-4-10(20-8)21(17,18)12-2/h3-5,12H,6H2,1-2H3,(H2,13,14,15,16) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-methyl-5-({[(5-methyl-1,2-oxazol-3-yl)carbamoyl]amino}methyl)thiophene-2-sulfonamide |
|
 | | N6D | | Name: | N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea | | Formula: | C13 H15 N3 O3 | | SMILES: | N(C(Nc1cccc(COC)c1)=O)c2cc(C)on2 | | InChi: | InChI=1S/C13H15N3O3/c1-9-6-12(16-19-9)15-13(17)14-11-5-3-4-10(7-11)8-18-2/h3-7H,8H2,1-2H3,(H2,14,15,16,17) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
 | | N6J | | Name: | N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea | | Formula: | C16 H15 N7 O2 | | SMILES: | N(c3cnn(Cc2cn1ccccc1n2)c3)C(Nc4cc(C)on4)=O | | InChi: | InChI=1S/C16H15N7O2/c1-11-6-14(21-25-11)20-16(24)19-12-7-17-23(9-12)10-13-8-22-5-3-2-4-15(22)18-13/h2-9H,10H2,1H3,(H2,19,20,21,24) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
 | | N6V | | Name: | N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea | | Formula: | C19 H25 N5 O2 | | SMILES: | n1(CCN(CC)CC)ccc2c1ccc(c2)NC(Nc3cc(C)on3)=O | | InChi: | InChI=1S/C19H25N5O2/c1-4-23(5-2)10-11-24-9-8-15-13-16(6-7-17(15)24)20-19(25)21-18-12-14(3)26-22-18/h6-9,12-13H,4-5,10-11H2,1-3H3,(H2,20,21,22,25) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
 | | N71 | | Name: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea | | Formula: | C13 H15 N3 O4 S | | SMILES: | N(CCS(c1ccccc1)(=O)=O)C(Nc2cc(C)on2)=O | | InChi: | InChI=1S/C13H15N3O4S/c1-10-9-12(16-20-10)15-13(17)14-7-8-21(18,19)11-5-3-2-4-6-11/h2-6,9H,7-8H2,1H3,(H2,14,15,16,17) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea |
|
 | | N74 | | Name: | N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea | | Formula: | C15 H15 N5 O2 | | SMILES: | N(c2cnn(Cc1ccccc1)c2)C(Nc3cc(C)on3)=O | | InChi: | InChI=1S/C15H15N5O2/c1-11-7-14(19-22-11)18-15(21)17-13-8-16-20(10-13)9-12-5-3-2-4-6-12/h2-8,10H,9H2,1H3,(H2,17,18,19,21) | | Definition date: | 2019-05-03 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
 | | H2N | | Name: | (2~{R})-4-[5-(2-fluoranyl-4-methoxy-phenyl)-2-oxidanylidene-1,3-oxazol-3-yl]-2-methyl-2-methylsulfonyl-~{N}-oxidanyl-butanamide | | Formula: | C16 H19 F N2 O7 S | | SMILES: | COc1ccc(c(F)c1)C2=CN(CC[C](C)(C(=O)NO)[S](C)(=O)=O)C(=O)O2 | | InChi: | InChI=1S/C16H19FN2O7S/c1-16(14(20)18-22,27(3,23)24)6-7-19-9-13(26-15(19)21)11-5-4-10(25-2)8-12(11)17/h4-5,8-9,22H,6-7H2,1-3H3,(H,18,20)/t16-/m1/s1 | | Definition date: | 2018-11-09 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | (2~{R})-4-[5-(2-fluoranyl-4-methoxy-phenyl)-2-oxidanylidene-1,3-oxazol-3-yl]-2-methyl-2-methylsulfonyl-~{N}-oxidanyl-butanamide |
|
 | | H2Q | | Name: | (2~{R})-4-[6-[4-[1-(hydroxymethyl)cyclopropyl]buta-1,3-diynyl]-3-oxidanylidene-1~{H}-pyrrolo[1,2-c]imidazol-2-yl]-2-methyl-2-methylsulfonyl-~{N}-oxidanyl-butanamide | | Formula: | C20 H23 N3 O6 S | | SMILES: | C[C](CCN1Cc2cc(cn2C1=O)C#CC#CC3(CO)CC3)(C(=O)NO)[S](C)(=O)=O | | InChi: | InChI=1S/C20H23N3O6S/c1-19(17(25)21-27,30(2,28)29)9-10-22-13-16-11-15(12-23(16)18(22)26)5-3-4-6-20(14-24)7-8-20/h11-12,24,27H,7-10,13-14H2,1-2H3,(H,21,25)/t19-/m1/s1 | | Definition date: | 2018-11-09 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | (2~{R})-4-[6-[4-[1-(hydroxymethyl)cyclopropyl]buta-1,3-diynyl]-3-oxidanylidene-1~{H}-pyrrolo[1,2-c]imidazol-2-yl]-2-methyl-2-methylsulfonyl-~{N}-oxidanyl-butanamide |
|
 | | H2Z | | Name: | (2~{R})-2-methyl-2-methylsulfonyl-4-[6-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]-3-oxidanylidene-1~{H}-pyrrolo[1,2-c]imidazol-2-yl]-~{N}-oxidanyl-butanamide | | Formula: | C25 H30 N4 O6 S | | SMILES: | C[C](CCN1Cc2cc(cn2C1=O)C#Cc3ccc(CN4CCOCC4)cc3)(C(=O)NO)[S](C)(=O)=O | | InChi: | InChI=1S/C25H30N4O6S/c1-25(23(30)26-32,36(2,33)34)9-10-28-18-22-15-21(17-29(22)24(28)31)8-5-19-3-6-20(7-4-19)16-27-11-13-35-14-12-27/h3-4,6-7,15,17,32H,9-14,16,18H2,1-2H3,(H,26,30)/t25-/m1/s1 | | Definition date: | 2018-11-09 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | (2~{R})-2-methyl-2-methylsulfonyl-4-[6-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]-3-oxidanylidene-1~{H}-pyrrolo[1,2-c]imidazol-2-yl]-~{N}-oxidanyl-butanamide |
|
 | | NJZ | | Name: | [3-bromanyl-5-(carbamimidoylsulfanylmethyl)phenyl]methyl carbamimidothioate | | Formula: | C10 H13 Br N4 S2 | | SMILES: | NC(=N)SCc1cc(Br)cc(CSC(N)=N)c1 | | InChi: | InChI=1S/C10H13BrN4S2/c11-8-2-6(4-16-9(12)13)1-7(3-8)5-17-10(14)15/h1-3H,4-5H2,(H3,12,13)(H3,14,15) | | Definition date: | 2019-12-02 | | Last modified: | 2019-12-13 | | Release date: | 2019-12-18 | | Identifier: | [3-bromanyl-5-(carbamimidoylsulfanylmethyl)phenyl]methyl carbamimidothioate |
|